These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment. Johannesson M J Hum Hypertens; 1996 Feb; 10 Suppl 2():S23-6. PubMed ID: 8868040 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines]. Fender P; Guilhot J; Tilly B; Salanave B; Allemand H Therapie; 2001; 56(2):111-8. PubMed ID: 11471361 [TBL] [Abstract][Full Text] [Related]
7. Cost analysis of different pharmacological treatment strategies in elderly hypertensives. Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B; Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488 [TBL] [Abstract][Full Text] [Related]
8. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies]. Rorive G; Delporte JP Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395 [TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen. Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B; Heart; 2008 Feb; 94(2):e4. PubMed ID: 17916665 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacological cost-efficacy of various schemes of combined antihypertensive therapy in elderly patients]. Red'kin IuV; Nikolaev NA Ter Arkh; 2005; 77(4):62-6. PubMed ID: 15938536 [TBL] [Abstract][Full Text] [Related]
11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
12. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark]. Keiding H; Hildebrandt P; Burke T; Carides GW Ugeskr Laeger; 2006 Oct; 168(42):3623-6. PubMed ID: 17069726 [TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive therapy in the elderly: results of large trials]. Leonetti G; Cuspidi C; Facchini M Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407 [TBL] [Abstract][Full Text] [Related]
14. Assessing the economic value of antihypertensive medications. Roth MS; Davenport RC; Simpson W Am J Manag Care; 1998 Sep; 4(9):1267-75. PubMed ID: 10185977 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of arterial hypertension: benefits, costs, challenges]. Zanchetti A Ann Ital Med Int; 1996 Oct; 11 Suppl 2():75S-81S. PubMed ID: 9004827 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [TBL] [Abstract][Full Text] [Related]
17. Medical and cost-economy aspects of modern antihypertensive therapy--with special reference to 2 years of clinical experience with losartan. Hansson L Blood Press Suppl; 1997; 1():52-5. PubMed ID: 9285110 [TBL] [Abstract][Full Text] [Related]
18. Observational study of hypertension in Matelica, Italy (Matelica hypertension study). Sossai P; Amenta F; Porcellati C Clin Exp Hypertens; 2007 Nov; 29(8):531-7. PubMed ID: 18058478 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents. Small RE; Freeman-Arnold SB; Goode JV; Pyles MA Pharmacotherapy; 1997; 17(5):1011-6. PubMed ID: 9324190 [TBL] [Abstract][Full Text] [Related]